Yoonsun Chung

Prof. Yoonsun Chung


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2024 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
EKEuidam Kim
Euidam Kim
YPYang Kyun Park
Yang Kyun Park
TZTianyu Zhao
Tianyu Zhao
ELEric Laugeman
Eric Laugeman
XZXiaodong Neo Zhao
Xiaodong Neo Zhao
HLHugh Lee
Hugh Lee
Purpose: The quality of on‐board imaging systems, including cone‐beam computed tomography (CBCT), plays a vital role in image‐guided radiation therapy (IGRT) and adaptive radiotherapy. Recently, there has been an upgrade of the CBCT systems fused in the O‐ring linear accelerators called HyperSight, featuring a high imaging performance. As the characterization of a new imaging system is essential, we evaluated the image quality of the HyperSight system by comparing it with Halcyon 3.0 CBCT and providing benchmark data for routine imaging quality assurance.Methods: The HyperSight features ultra‐fast scan time, a larger kilovoltage (kV) detector, a more substantial kV tube, and an advanced reconstruction algorithm. Imaging protocols in the two modes of operation, treatment mode with IGRT and the CBCT for planning (CBCTp) mode were evaluated and compared with Halcyon 3.0 CBCT. Image quality metrics, including spatial resolution, contrast resolution, uniformity, noise, computed tomography (CT) number linearity, and calibration error, were assessed using a Catphan and an electron density phantom and analyzed with TotalQA software.Results: HyperSight demonstrated substantial improvements in contrast‐to‐noise ratio and noise in both IGRT and CBCTp modes compared to Halcyon 3.0 CBCT. CT number calibration error of HyperSight CBCTp mode (1.06%) closely matches that of a full CT scanner (0.72%), making it suitable for adaptive planning. In addition, the advanced hardware of HyperSight, such as ultra‐fast scan time (5.9 s) or 2.5 times larger heat unit capacity, enhanced the clinical efficiency in our experience.Conclusions: HyperSight represented a significant advancement in CBCT imaging. With its image quality, CT number accuracy, and ultra‐fast scans, HyperSight has a potential to transform patient care and treatment outcomes. The enhanced scan speed and image quality of HyperSight are expected to significantly improve the quality and efficiency of treatment, particularly benefiting patients.

24 October 2018 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
PDF file
ECEunah Chung
Eunah Chung
DKDongyeol Kwon
Dongyeol Kwon
TPTaeyang Park
Taeyang Park
HKHyeri Kang
Hyeri Kang
YCYoonsun Chung
Yoonsun Chung
1 Purpose The delivery quality assurance (DQA) of intensity‐modulated radiotherapy (IMRT) plans is a prerequisite for ensuring patient treatments. This work investigated the clinical usefulness of a new DQA system, Dosimetry Check™(DC), on TomoTherapy®‐based helical IMRT plans. 2 Methods The DQA was performed for 15 different TomoTherapy®‐based clinical treatment plans. In Tomotherapy® machines, the couch position was set to a height of 400 mm and the treatment plans were delivered using QA‐Treatment mode. For each treatment plan, the plan data and measured beam fluence were transferred to a DC‐installed computer. Then, DC reconstructed the three‐dimensional (3D) dose distribution to the CT images of the patient. The reconstructed dose distribution was compared with that of the original plan in terms of absolute dose, two‐dimensional (2D) planes and 3D volume. The DQA results were compared with those performed by a conventional method using the cheese phantom with ion chamber and radiochromic film. 3 Results For 14 out of the 15 treatment plans, the absolute dose difference between the measurement and calculation was less than 3% and the gamma pass rate with the 3%/3 mm gamma evaluation criteria was greater than 95% for both DQA methods. The P‐value calculated using Wilcoxon signed‐rank test was 0.256, which implies no statistically significance in determining the absolute dose difference between the two methods. For one treatment plan generated using the 5.0 cm field width, the absolute dose difference was greater than 3% and the gamma pass rate was less than 95% with DC, while the DQA result with the cheese phantom method passed our TomoTherapy® DQA tolerance. 4 Conclusion We have clinically implemented DC for the DQA of TomoTherapy®‐based helical IMRT treatment plans. DC carried out the accurate DQA results as performed with the conventional cheese phantom method. This new DQA system provided more information in verifying the dose delivery to patients, while simplifying the DQA process.

8 May 2019 in The Breast Journal
Verified
Journal Article
Closed access
PDF file
KYKyungmi Yang
Kyungmi Yang
WPWon Park
Won Park
SJSang Gyu Ju
Sang Gyu Ju
YCYoonsun Chung
Yoonsun Chung
DCDoo Ho Choi
Doo Ho Choi
CNCho Hee Na
Cho Hee Na

1 November 2022 in Nuclear Engineering and Technology
Verified
Journal Article
Open access
TKTae-Eun Kwon
Tae-Eun Kwon
AJAreum Jeong
Areum Jeong
WHWi-Ho Ha
Wi-Ho Ha
DLDalnim Lee
Dalnim Lee
SSSongwon Seo
Songwon Seo
SPSunhoo Park
Sunhoo Park
The Korea Institute of Radiological and Medical Sciences has started a radiation epidemiological study, titled “Korean Radiation Worker Study,” to evaluate the health effects of occupational exposure to radiation. As a part of this study, we investigated the methodologies and results of reconstructing organ-specific absorbed doses based on personal dose equivalent, Hp(10), reported from 1984 to 2019 for 20,605 Korean radiation workers. For the organ dose reconstruction, representative exposure scenarios (i.e., radiation energy and exposure geometry) were first determined according to occupational groups, and dose coefficients for converting Hp(10) to organ absorbed doses were then appropriately taken based on the exposure scenarios. Individual annual doses and individual cumulative doses were reconstructed for 27 organs, and the highest values were observed in the thyroid doses (on average 0.77 mGy/y and 10.47 mGy, respectively). Mean values of individual cumulative absorbed doses for the red bone marrow, colon, and lungs were 7.83, 8.78, and 8.43 mSv, respectively. Most of the organ doses were maximum for industrial radiographers, followed by nuclear power plant workers, medical workers, and other facility workers. The organ dose database established in this study will be utilized for organ-specific risk estimation in the Korean Radiation Worker Study.

4 January 2021 in Journal of Radiological Protection
Verified
Journal Article
Open access
PDF file
TKTae-Eun Kwon
Tae-Eun Kwon
YCYoonsun Chung
Yoonsun Chung
YJYoung Woo Jin
Young Woo Jin
The International Commission on Radiological Protection (ICRP) recently adopted a detailed biokinetic model for systemic iodine with reference transfer coefficients based on typical worldwide dietary intakes of stable iodine. The regional data provided demonstrate that the ICRP reference thyroidal biokinetics may differ substantially across regions with atypically low or high dietary intakes of stable iodine. Importantly, the design of the ICRP model facilitates modifications of reference thyroidal kinetics based on regional dietary iodine intake. The present study extended the ICRP model to the South Korean population, whose dietary iodine intake is much higher than the global mean. The following three transfer coefficients were selected as targets for Korean-specific values: thyroidal uptake rate (λ 1), hormonal secretion rate (λ 4) and leakage rate of thyroidal organic iodine as inorganic iodide (λ 5). The Korean-specific values for λ 1, λ 4 and λ 5 were determined to be 4.48, 0.0086 and 0.0171 d−1, respectively, to yield the measurements of thyroidal iodine and physiological status of Korean adults. The determined λ 1 and λ 5 values differed noticeably from the ICRP values, whereas the λ 4 value was comparable to that of the ICRP. Compared with the ICRP reference model, the Korean model, in which the Korean-specific transfer coefficients were adopted, predicted noticeably lower thyroidal uptake and faster decrease of thyroidal iodine. In addition, the predicted cumulative activities of radioiodine in the thyroid were substantially lower (40–80%) than those predicted by the ICRP model. The Korean model developed in this study demonstrates that the iodine biokinetics for Koreans (i.e. a population with a high iodine consumption) obviously differ from the prediction of the ICRP model. Hence, the Korean model may serve to improve the accuracy of thyroid dose estimation for Koreans and will lead to practical changes in matters concerned with radiological protection.

17 March 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JLJoongyo Lee
Joongyo Lee
EKEuidam Kim
Euidam Kim
NKNalee Kim
Nalee Kim
HBHwa Kyung Byun
Hwa Kyung Byun
CSChang-Ok Suh
Chang-Ok Suh
HYHong In Yoon
Hong In Yoon
We investigated the practical aspects of the application of craniospinal irradiation using helical tomotherapy (HT-CSI) by evaluating interfractional setup errors and intrafractional movement during each treatment in 83 patients undergoing HT-CSI between January 2014 and December 2018. Interfractional setup errors in each axis (mediolateral; ML, craniocaudal; CC, and anteroposterior; AP) were assessed as differences between pre-treatment megavoltage computed tomography (MVCT) images scanned (zygomatic arch to the C4 spine) and planning CT images. Intrafractional movements were evaluated as the difference between pre-treatment and post-treatment MVCT (T12–L4 spine) images at each fraction. Median interfractional setup error was acceptable in every axis (ML: 1.6 mm, CC: 1.9 mm, AP: 3.1 mm). Seven patients (8.4%) experienced significant intrafractional displacement from 1 to 10 fractions (0.34% for ML, 0.74% for CC, 1.21% for AP). Weight loss grade 1+ during treatment (p = 0.016) was an independent risk factor for significant intrafractional displacement. The risk factor for significant intrafractional movement in pediatric patients was weight loss grade 1+ (p = 0.020), while there was no factor in adults. HT-CSI could be a feasible treatment modality with acceptable setup verification. Inter- and intrafractional errors were acceptable; paying attention to weight loss during treatment is necessary, especially in pediatric patients.